Status:

COMPLETED

Bifido- and Lactobacilli in Symptomatic Adult COVID-19 Outpatients

Lead Sponsor:

Nordic Biotic Sp. z o.o.

Conditions:

COVID-19 Respiratory Infection

Eligibility:

All Genders

18-65 years

Phase:

NA

Brief Summary

There is evidence that some types of probiotics play a role in alleviation of symptoms of acute respiratory tract infections and bursting immune response to respiratory and enteric viruses. Available ...

Detailed Description

One hundred adults with confirmed (PCR or antigen test) symptomatic COVID-19 lasting upto 5 days will be screened for the study. When the subject meets enrollment criteria, he/she will be randomized t...

Eligibility Criteria

Inclusion

  • Age ≥ 18 - ≤ 65 years;
  • Male or non-pregnant female;
  • Informed virtual pre-consent and paper signed consent forms;
  • Confirmed symptomatic COVID-19 lasting 0-5 days;
  • Subject understands and agrees to comply with study procedures including triple blood analysis for anti-SARS-CoV-2 IgG;

Exclusion

  • Risk for the complicated course of COVID-19 due to:
  • 1. Hypertension; 1.2. Diabetes mellitus; 1.3. Immunosuppressive conditions; 1.4. Chronic pathology of the respiratory system ; 1.5. Chronic pathology of the cardiovascular system ; 1.6. Malignant tumor ; 1.7. Systemic inflammatory connective tissue disease ; 1.8. Cerebrovascular disease ; 1.9. Chronic hepatitis. Hepatic cirrhosis; 1.10. Inflammatory bowel diseases ; 1.11. Chronic kidney disease ;
  • Drug or alcohol abuse as suspected by investigator;
  • History of persistent diarrhea of any cause;
  • Use of pre- or probiotics during the last 2 weeks before enrollment;
  • Allergy to any components of the TDS;
  • Technical difficulties to perform virtual study visits.
  • Inability to perform a blood test for antibodies after 6 months
  • Inability to swallow capsules, or choking / coughing while eating

Key Trial Info

Start Date :

December 1 2021

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

March 1 2023

Estimated Enrollment :

70 Patients enrolled

Trial Details

Trial ID

NCT04907877

Start Date

December 1 2021

End Date

March 1 2023

Last Update

March 22 2023

Active Locations (3)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (3 locations)

1

Hemo Medica Ukraine Ltd

Uzhhorod, Zakarpatska, Ukraine, 88000

2

Lviv State Center for Disease Control and Prevention

Lviv, Ukraine, 79014

3

3rd City Clinical Hospital of Lviv

Lviv, Ukraine, 79016